BioLogic Gates, a foundational concept in synthetic biology, introduces engineering-level precision into complex biological systems by enabling programmable control over gene expression. These gates utilize modular genetic components—such as promoters, transcription factors, and RNA regulators—to execute logic-based operations (NOT, AND, OR, NAND, NOR, XOR) within living cells including Escherichia coli, yeast, and mammalian systems. By simulating the behavior of electronic logic gates, these biological circuits process multiple molecular inputs and generate discrete, interpretable outputs in response to environmental and cellular stimuli. Despite intrinsic challenges related to stability, orthogonality, and scalability, recent advances in computational modeling, directed evolution, and modular circuit architecture have significantly enhanced their reliability and performance. The applicability of BioLogic Gates spans numerous domains including biosensing, diagnostics, and therapeutic design. In biosensors, gates like AND enhance specificity by requiring co-occurrence of biomarkers to trigger responses. In drug delivery, logic circuits enable condition-specific release of therapeutics, improving efficacy and minimizing systemic side effects. As synthetic biology continues to advance, the integration of BioLogic Gates with metabolic circuits, nanomaterials, and programmable gene networks will pave the way for next-generation solutions in precision medicine, environmental monitoring, and bio-computational systems.